Procedure
Michigan Neuropathy Screening Instrument
Michigan Neuropathy Screening Instrument is a medical procedure with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Phase 1Safety & dosage
1(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Completed1
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (100.0%)
Trials by Status
completed133%
recruiting133%
unknown133%
Recent Activity
1 active trials
Showing 3 of 3
recruiting
Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy
NCT05642143
completed
The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality
NCT06188572
unknownphase_1
The Effectiveness of Improving Self-care After Counseling for the Diabetics Mellitus Foots Around Chiayi Region
NCT01299246
Clinical Trials (3)
Showing 3 of 3 trials
NCT05642143
Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy
NCT06188572
The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality
NCT01299246Phase 1
The Effectiveness of Improving Self-care After Counseling for the Diabetics Mellitus Foots Around Chiayi Region
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3